Forty-two patients with pure mitral stenosis underwent a prospective, longitudinal study with two or more cardiac catheterizations 1 to 10 years apart and without intervening surgical treatment. The majority of patients had not previously had mitral valve surgery; in 16, the period of observation followed valvotomy. Twenty-seven patients showed evidence of progressive obstruction of the mitral valve; 15 showed no change in the calculated mitral valve area. In the group of patients with progressive disease (stenosis or restenosis) there was a consistent clinical and hemodynamic deterioration: 25 of the 27 showed increasing disability. In the nonprogressive group, seven of the 15 showed increasing symptomatology, most often related to the development of atrial fibrillation and a fall in cardiac output. Possible causes for the different course of mitral stenosis in the two groups are reviewed. The probability that trauma due to altered flow patterns through a stenotic valve produces progressive stenosis is suggested.
Mitral valve area entire spectrum of mitral stenosis, and found that 21% of the patients survived 20 years. Using these data, Ellis et al.3 demonstrated that mitral valvotomy produces a significant reduction in mortality.
Clinical studies, such as those quoted above, fail to provide information regarding the most crucial question pertaining to the natural history of mitral stenosis: is the clinical deterioration caused by a progression of the valve disease, or is it caused by secondary sequelae in a condition that is "burned out" early in life?
An ideal way of determining the course of mitral valve obstruction would be the organization of a longitudinal study, with repetition of hemodynamic measurements at intervals. Such a study, however, could not take place today, for it is not possible to withhold surgical treatment from severely disabled patients. The present, prospective study deals with data gathered from periodic reevaluation of patients with mitral stenosis in whom intervening surgical treatment was not performed. These patients obviously do not represent a complete sample of the various stages of mitral stenosis and provide only partial insight into the course of this lesion. Nevertheless, it is believed that important information has been obtained that can be extrapolated into a more complete understanding of the disease. Inasmuch as a number of patients are known to develop progressive restenosis following valvotomy, we have included patients who have had two hemodynamic studies performed after mitral valvotomy, as an important aspect of the natural history of mitral stenosis.
Materials and Methods
All patients with pure or almost pure mitral stenosis who underwent two or more cardiac catheterizations without intervening mitral valve operations were included in this series, a total of 42 cases. In the assessment of clinical symptomatology, particular attention was paid to the progression of disability; a composite range of the various symptoms was considered, such as effort dyspnea and fatigue, as well as symptoms at rest (nocturnal dyspnea, orthopnea, and pulmonary edema). Temporary variations in symptomatology were discounted; patients who developed atrial fibrillation had their symptoms assessed after ventricular rate had been properly controlled.
Cardiac catheterization was performed by means of the standard technique. [14] [15] [16] In the earlier cases, only right-heart catheterization was done, with a properly recorded tracing of pulmonary artery wedge pressure considered to be equivalent to the left atrial pressure. In more recent studies combined rightand left-sided cardiac catheterizations were performed in most cases. Cardiac output was determined by the Fick formula. Resistances within the pulmonary circulation (total and vascular) were calculated in accordance with the accepted formulae,14' 15 and were reduced to a standard size, expressed as dynes-sec-cm-5/1.7 m2 of body surface area. The mitral valve area was calculated according to the formula by Gorlin and Gorlin,17 from either assumed (5 mm Hg) or measured left ventricular diastolic pressures.
The timing of the second cardiac catheterizations was unrelated to any specific pattern. In general, 2to 4-year intervals were aimed at, but many of the studies were determined by the availability of the patients and their willingness to be subjected to repeated catheterizations.
In addition to patients who underwent serial cardiac studies, a group of 19 patients with mild mitral stenosis who had only a single hemodynamic study were reviewed for the purpose of comparison of their course with the subjects under study. These patients felt well and did not wish to have another cardiac catheterization performed.
Results
As the study continued, it became apparent that in some patients the calculated area of the mitral valve decreased, while in others the area remained unchanged. Such observations were made both in patients who had never undergone cardiac surgery and in those who had previously had mitral valvotomies. Therefore, the patients were divided into two principal groups: those with progressive mitral stenosis and those with nonprogressive mitral stenosis (table 1). The time interval between the two studies ranged from 1 to 8 years, averaging 2.6 years in the progressive group. In the nonprogressive group, this interval varied from 1 to 10 years, with a mean of 3.7 years.
Progressive Mitral Stenosis
The progressive group comprised 27 patients, nine of whom had had previous mitral valvotomies. The reduction of the calculated mitral valve area ranged from 0.3 to 1.5 cm2, with a mean of 0.6 cm2. If this reduction is presented in terms of percentage of the original valve area, the mitral orifice stenosed by a minimum of 12% and a maximum of 55%, with a mean of 36%. The progression, expressed as a rate, averaged 0.32 cm2/year (19%/year).
Four patients in the progressive group had three studies performed, with intervals between the first and third studies ranging from 23M to 5 years, and in three of the four progression of stenosis occurred between each of the studies.
Other hemodynamic changes coinciding with a decrease in the mitral valve area included fall in cardiac output, which changed by at least 0.2 liter/min/m2 in 21 out of 27 patients in this group; in 15 of these the decrease in flow was considerable (over 25%). Sixteen patients had developed an abnormally low cardiac output at the second study (.'2.5
Circulation, Volume XLIV, September 1971 liters/min/M2). All nine patients who changed from sinus rhythm to atrial fibrillation between studies showed a fall in cardiac output. An increase in resting left atrial pressure and pulmonary arterial pressure occurred in most cases, even though the cardiac output had decreased. Pulmonary vascular resistance as a rule increased in patients in whom atrial fibrillation developed, but such an increase also occurred in some patients who remained in sinus rhythm. The appearance of severe pulmonary hypertension was uncommon. Thus, high pulmonary vascular resistance (400 dynes-sec-cm-5t 1.7 M2) was originally present in two patients, and such levels developed in only four others.
Nonprogressive Mitral Stenosis
Seven of the 15 patients had cardiac outputs within the normal range. A significant fall in cardiac output occurred in seven patients; however, in two of these, cardiac output still remained within the normal range. Atrial fibrillation developed between studies in six patients; five of those showed a coincidental fall in cardiac output. An abnormally high pulmonary vascular resistance was present at the time of the first study in two patients. No patient acquired severe pulmonary hypertension.
Comparison of the Two Groups
The age of the patients varied between 28 and 62 years in the progressive group (mean, 45.3 years) and between 25 and 60 in the nonprogressive group (mean, 41.8 years). The difference between the two groups is statistically not significant. An increase in the degree of disability at the time of the second study was observed in 32 of the 42 patients. Of these, 25 fell into the group of progressive mitral stenosis, leaving only two patients with unchanged symptomatology in this group. Table 1 shows that the increase in disability generally coincided with the onset of atrial fibrillation, a fall in resting cardiac output, and/or an increase in pulmonary capillary pressure. Seven of the fifteen patients in the group with stable mitral valve area became more symptomatic, and among these were the Circulation, Volume XLIV, September 1971 five patients who changed from sinus rhythm into atrial fibrillation and concomitantly manifested a fall in cardiac output.
As previously indicated, the material in this series was supplemented by clinical follow-up observations in 19 patients with mild mitral stenosis who underwent only an initial hemodynamic evaluation. These patients were seen again after an average of 3 years, and none of them showed increase in symptoms.
The possibility of rheumatic activity was considered in the patients of this series. There were no instances where such activity could be documented by elevation of sedimentation rate or a high antistreptolysin titer.
Discussion
Proper interpretation of the results of this study necessitated careful consideration of its limitations. Cases included in this study are subject to two obvious biases: first, patients with less severe forms of mitral stenosis were more likely to be the subjects of a longitudinal study, since they were not surgical candidates; second, follow-up catheterization undoubtedly was preferentially performed in patients who developed progressive symptoms. However, the series contains a sufficient representation of patients with moderate or severe mitral stenosis, who, for various reasons, did not wish to undergo cardiac surgery, so that a broad spectrum of this disease is presented. The second bias has been partially corrected by review of the clinical follow-up of patients with mild mitral stenosis who underwent only a single hemodynamic study.
A limiting factor in the study (as well as in other hemodynamic studies of mitral stenosis) is the accuracy of the Gorlin formula, which is based on a number of assumptions. However, it should be noted that the calculated mitral valve area shows a surprisingly good reproducibility in two separate cardiac catheterizations, when performed within short periods of time, regardless of whether it is based on an indirect measurement of left atrial pressure (by means of a pulmonary arterial wedge tracing) or on a measured transvalvular gradient (personal observations). One can, L2 00 < < 003)00 9 X C3 n 0 + 00 O 00 X 00000 + 000000 s t' 00 + t 00 therefore, assume that with properly executed measurements and calculations the error should not exceed 10%. Moreover, any error should be random, allowing either an increase or decrease in valve area. Since an increase was not observed, this type of error is thought to play a minor role and not to bias the results unduly.
The principal yield of our study is the finding that mitral stenosis appears as a progressive disease in some patients and as a nonprogressive disease in others. The validity of this finding has to be examined critically. A hypothesis, that mitral stenosis is basically a stable disease and that the findings represent random variations of measurements, can be dismissed easily, because in no case has there been a significant increase in mitral valve area between studies. The opposite thesis, that mitral stenosis progressed in all patients but that the difference between cases represents variations in the rate of change, cannot be dismissed with equal ease, but appears highly improbable. The separation of the groups is moderately well defined. Although the rate of progression showed a wide variation, in the majority of patients in the progressive group the rate was fairly rapid. Furthermore, three out of four patients in whom two follow-up studies were performed showed a consistent rate of progression of mitral stenosis. On the other hand, an unchanged mitral valve area was noted in the nonprogressive group after as long as 10 years follow-up. Thus, although it appears reasonable to accept the separation of the two groups of patients with mitral stenosis, the length of observation does not permit us to conclude whether there are two distinct forms of mitral stenosis, or whether one is merely dealing with different stages in the life history of mitral stenosis.
It is seen that progression of mitral stenosis almost uniformly leads to a parallel progression of clinical symptomatology (25 of 27 patients-93%). In the nonprogressive group, disability may also develop (seven of 15 cases-46%). However, in this group, the disability appears to be related mostly to a secondary complication, atrial fibrillation (five Cifculation, Volume XLIV, September 1971 of seven patients ). Increase in disability usually coincided with deterioration of the various hemodynamic measurements, such as lower resting cardiac output (in both groups) and increased resting pulmonary artery wedge pressure (seen in the progressive group).
The ratio of progressive to nonprogressive cases of mitral stenosis in this series is 2:1. This ratio is an obvious reflection of the aforementioned bias in selection of patients. The supplemental data of patients with mild mitral stenosis reveal that all 19 patients with a single study and a clinical follow-up showed no change in clinical symptomatology. It is noted that clinical disability fails to develop in only 7% of patients with progressive mitral stenosis, and that 54% of patients with nonprogressive mitral stenosis remain symptomatically stable. Therefore, it is reasonable to assume that these 19 patients with stable symptoms did not have progression of mitral stenosis. On the basis of this (admittedly crude) calculation, one can surmise that the number of nonprogressive cases is underestimated, and that the corrected ratio in an unselected series might indicate an equal number or preponderance of nonprogressive cases.
When one tries to apply our observations to the broader spectrum of the natural history of mitral stenosis, it is necessary to ask a crucial question: why do some patients show rapid progression of mitral stenosis while others appear to have their disease arrested? A definite answer to this question is not available, but some tentative ideas are worthy of consideration.
The active rheumatic process is primarily responsible for the earliest changes in the mitral valve. It is unlikely, however, that progression of mitral stenosis in the middleaged patient represents a continuation of rheumatic activity. This notion is supported by three lines of thinking: first, active rheumatic fever in the age group of patients in this series is rare in our geographical locale; second, the usual tests for rheumatic activity were generally normal in both groups; finally, increasing evidence is being accumulated that shows that the stenotic process (or other organic disease of valve cusps) in "rheumatic" valve disease is caused by a self-perpetuating, noninflammatory process.
The concept of nonspecific valve thickening caused by trauma from altered flow patterns through an anatomically abnormal valve is most widely recognized in aortic stenosis: calcific aortic stenosis in the middle-aged or elderly patients is the end result of a nonspecific process that leads to an identical appearance of the valve, regardless of whether the underlying process is rheumatic valvulitis or a congenital valve deformity."8 It has also been suggested that, in mitral regurgitation due to isolated rupture of chordae tendineae, fibrotic thickening of the mitral valve may occur from such trauma. 19 One could thus look upon late progression of mitral stenosis as a self-perpetuating pathologic process related to the trauma of altered flow through a stenotic valve. It is possible that some conditions tend to facilitate progression, for example, stiff calcified valves. Conversely, one can expect circumstances in which flow follows a more normal pattern, such as in cases with mobile valves restricted only at their periphery by commissural fusion. It also appears plausible that mitral valvotomy under favorable circumstance (e.g., selective commissural fusion) could produce lasting relief of the stenosis, although operation on fibrocalcific valve leaflets would merely reset the progressive process at a different level, without arresting it.
The question of restenosis of the mitral valve after valvulotomy has been subject to some controversy.20-23 This controversy primarily concerns how often restenosis occurs, as against how often recurrence of symptoms may be attributed to unsuccessful valvotomy. Our data do not permit an estimation of the frequency and rapidity of restenosis; however, restenosis was documented in patients with 3xcellent valvotomy as well as others who had obtained only partial relief from the operation. One need not hesitate to apply the term restenosis in this connotation, since its meaning does not limit recurrent obstruction of the valve to cases where total relief of stenosis was obtained.
In answer to the question posed in the introduction, then, one can state on the basis of this study that development or progression of clinical disability is generally related to progressive narrowing of the mitral orifice. In the majority of instances, the progressive stenosis of the valve is accompanied by hemodynamic deterioration, such as a decrease in resting cardiac output and increase in pulmonary capillary pressures; marked change in pulmonary vascular resistance is uncommon. Disability may also develop in the presence of stable mitral valve disease, in which case it is usually related to the onset of atrial fibrillation and a consequent lowering of cardiac output.
